Longevity Industrialized

An indication selection resource for longevity companies

We're sharing a spreadsheet with key data on 47 diseases that aging drugs could potentially treat, to help fresh startups and academic scientists pick…

Mar 25 • Norn Group

12

1

6

Advancing Longevity Trials: Lessons from mTOR-Targeting Interventions

What two decades of trials can teach us about translating rapamycin to human aging.

Mar 7 • Norn Group and Nicolas Di Leo

10

3

January 2026

Field Notes: JPM 2026

Healthcare bursting at the seams, and a national longevity strategy roundtable.

Jan 21

8

1

4

Do we have a useful aging clock?

13 years after the first 'aging clock' was published we're still measuring mouse lifespan and unable to run human aging trials. What's missing?

Jan 2 • Martin Borch Jensen

11

2

4

December 2025

The Slop Map

A Field Guide to Longevity Content

Dec 17, 2025 • Martin Borch Jensen and Effie Klimi

12

4

2

Norn Notes 20251201

Nucleus Genomics is a longevity company?

Dec 1, 2025

1

1

November 2025

How to Design a Clinical Trial for Aging

Current incentives push companies away from true aging drugs and toward single-indication development. This essay suggests an ‘aging’ Phase III trial…

Nov 26, 2025 • Martin Borch Jensen, Márton Mészáros, Brennan Overhoff, and Norn Group

17

5

6

October 2025

Why there are no trillion-dollar biotechs

Nvidia is worth more than every pharmaceutical company. Some say biotech CEOs should see this as a challenge. But if they try for the big T, markets…

Oct 15, 2025 • Martin Borch Jensen

28

3

3

September 2025

Avoiding the Gerontocene

America’s choices on policy and research priorities today could determine whether the coming decade brings us yet closer to a shrinking fraction of…

Sep 21, 2025 • Martin Borch Jensen, Sean Simonini, and Eshan Mehra

6

3

Field notes: ARDD 2025

An exciting aging conference (w 995 schedule + drinks... thanks CH+DK organizers). Pharma paying attention to longevity like never before. New…

Sep 1, 2025 • Martin Borch Jensen

9

2

August 2025

How Does Life Become Worth Investing In?

On May 1st 2025 Meta and Microsoft reported high earnings and added ~$360 billion in market cap, as much as the value of the pharma companies Pfizer…

Aug 21, 2025 • Martin Borch Jensen

4

1

Welcome

Introducing Life Expansion, a newsletter covering progress in longevity

Aug 21, 2025 • Martin Borch Jensen

1